IRIS
GANDAGLIA, GIORGIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.328
AS - Asia 9.107
NA - Nord America 7.174
SA - Sud America 2.612
Continente sconosciuto - Info sul continente non disponibili 489
AF - Africa 201
OC - Oceania 13
AN - Antartide 1
Totale 29.925
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.789
RU - Federazione Russa 5.204
SG - Singapore 3.205
CN - Cina 2.453
IT - Italia 2.355
BR - Brasile 2.127
HK - Hong Kong 1.300
SE - Svezia 1.033
VN - Vietnam 947
FR - Francia 488
BD - Bangladesh 347
DE - Germania 288
AR - Argentina 214
NL - Olanda 190
GB - Regno Unito 178
CA - Canada 175
IN - India 160
FI - Finlandia 154
JP - Giappone 138
TR - Turchia 91
MX - Messico 81
IQ - Iraq 79
CO - Colombia 75
ID - Indonesia 72
IE - Irlanda 71
EC - Ecuador 67
PL - Polonia 66
ZA - Sudafrica 66
AT - Austria 64
ES - Italia 55
MA - Marocco 46
PK - Pakistan 41
SA - Arabia Saudita 35
VE - Venezuela 32
UA - Ucraina 29
CL - Cile 27
PY - Paraguay 27
MY - Malesia 26
NP - Nepal 26
PH - Filippine 23
UZ - Uzbekistan 23
CR - Costa Rica 22
LT - Lituania 22
AE - Emirati Arabi Uniti 20
JM - Giamaica 19
PE - Perù 19
TN - Tunisia 18
EG - Egitto 17
DO - Repubblica Dominicana 16
KE - Kenya 16
CZ - Repubblica Ceca 14
HN - Honduras 14
KR - Corea 13
UY - Uruguay 13
BE - Belgio 12
CH - Svizzera 12
DZ - Algeria 12
JO - Giordania 12
PT - Portogallo 12
IL - Israele 11
MD - Moldavia 11
BG - Bulgaria 10
KZ - Kazakistan 10
AU - Australia 9
AZ - Azerbaigian 9
BO - Bolivia 9
GT - Guatemala 9
LB - Libano 9
NI - Nicaragua 8
PR - Porto Rico 8
BA - Bosnia-Erzegovina 7
HU - Ungheria 7
IR - Iran 7
NO - Norvegia 7
TT - Trinidad e Tobago 7
AL - Albania 6
BB - Barbados 6
DK - Danimarca 6
ET - Etiopia 6
PA - Panama 6
SV - El Salvador 6
TH - Thailandia 6
BH - Bahrain 5
GR - Grecia 5
OM - Oman 5
RO - Romania 5
AM - Armenia 4
CG - Congo 4
CY - Cipro 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BW - Botswana 3
BY - Bielorussia 3
KG - Kirghizistan 3
KH - Cambogia 3
KW - Kuwait 3
MK - Macedonia 3
NZ - Nuova Zelanda 3
PS - Palestinian Territory 3
RS - Serbia 3
Totale 29.397
Salva come PNG Salva come JPEG
Città #
Singapore 1.313
Hong Kong 1.286
Moscow 1.213
Dallas 802
Ashburn 777
San Jose 737
Council Bluffs 512
Shanghai 473
Milan 463
Hefei 440
Lawrence 412
Princeton 408
Lauterbourg 385
Ho Chi Minh City 341
New York 291
Santa Clara 274
Beijing 272
Hanoi 209
Rome 188
Los Angeles 169
São Paulo 164
Helsinki 106
Dublin 71
Rio de Janeiro 71
Turin 70
Munich 65
Nuremberg 64
Chicago 54
Orem 53
Warsaw 53
Boston 50
Montreal 50
Tokyo 50
Boardman 49
Phoenix 49
Seattle 49
Florence 47
Brooklyn 45
Belo Horizonte 44
Bologna 44
Da Nang 44
Atlanta 40
Buffalo 37
Chennai 37
Verona 37
Brasília 36
Naples 36
Curitiba 34
Guangzhou 34
Haiphong 34
Porto Alegre 34
Miami 33
Palermo 33
Turku 31
Denver 30
Houston 30
Toronto 30
Bari 29
Johannesburg 29
Baghdad 28
Frankfurt am Main 28
Manchester 28
Omaha 28
Vienna 28
Biên Hòa 27
Genoa 27
London 27
Stockholm 26
Brescia 25
Salvador 25
Amsterdam 24
Ankara 24
Mexico City 24
San Francisco 24
Buenos Aires 23
Columbus 23
Guayaquil 23
The Dalles 23
Manaus 21
Fortaleza 20
Kuala Lumpur 20
Memphis 20
Pune 20
Tashkent 20
Thái Bình 20
Washington 20
Campinas 19
Changsha 19
Dhaka 19
Goiânia 19
Paris 19
Poplar 19
Tianjin 19
Catania 18
Erbil 18
Philadelphia 18
Hangzhou 17
Ninh Bình 17
Betim 16
Mumbai 16
Totale 13.760
Salva come PNG Salva come JPEG
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 2.102
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 252
[18F]Fluoro-Deoxy-Glucose positron emission tomography to evaluate lymph node involvement in patients with muscle-invasive bladder cancer receiving neoadjuvant pembrolizumab 236
[C-11]Choline PET/CT predicts survival in hormone-naive prostate cancer patients with biochemical failure after radical prostatectomy 184
A NOVEL MODEL INTEGRATING CLINICAL, MP-MRI, AND EPIGENOMIC FEATURES TO PREDICT LYMPH NODE INVASION IN PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY AND PELVIC LYMPH NODE DISSECTION 179
The Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Assessment of Local Recurrence and Distant Metastases in Patients with Biochemical Recurrence of Prostate Cancer After Definitive Treatment: A Systematic Review and Meta-analysis 175
68Ga-PSMA-PET/CT Scan as Primary Staging for Prostate Cancer and Its Related Clinical Implications 156
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 152
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 147
A Novel Nomogram to Identify Candidates for Extended Pelvic Lymph Node Dissection Among Patients with Clinically Localized Prostate Cancer Diagnosed with Magnetic Resonance Imaging-targeted and Systematic Biopsies 142
[Management of erectile dysfunction in patients with preexisting cardiovascular disease]. FT Disfunzione erettile nel paziente cardiopatico: diagnosi e raccomandazioni terapeutiche. 141
A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma 137
A MINIMUM OF 14 CORES SHOULD BE TAKEN AT BIOPSY BEFORE PLANNING ACTIVE SURVEILLANCE FOR PATIENTS WITH LOW-RISK PROSTATE CANCER 136
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study 136
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer 135
ROBOT-ASSISTED RADICAL PROSTATECTOMY IS ASSOCIATED WITH FASTER AND GREATER RECOVERY FROM ORGASM ASSOCIATED INCONTINENCE 130
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 130
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 129
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 128
Time for action: actinium-225 PSMA-targeted alpha therapy for metastatic prostate cancer – a systematic review and meta-analysis 128
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 127
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 124
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 124
Upper Tract Urothelial Carcinoma in the Lynch Syndrome Tumour Spectrum: A Comprehensive Overview from the European Association of Urology - Young Academic Urologists and the Global Society of Rare Genitourinary Tumors 124
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 124
A Head-to-head Comparison of Four Prognostic Models for Prediction of Lymph Node Invasion in African American and Caucasian Individuals 123
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ 120
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 119
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 119
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 118
A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy 116
A real-world comparison of docetaxel versus abiraterone acetate for metastatic hormone-sensitive prostate cancer 116
Which Patients with Prostate Cancer and Lymph Node Uptake at Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computerized Tomography Scan Are at a Higher Risk of Prostate-specific Antigen Persistence After Radical Prostatectomy? Identifying Indicators of Systemic Disease by Integrating Clinical, Magnetic Resonance Imaging, and Functional Imaging Parameters 115
Re: Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-Invasive Bladder Carcinoma with Variant Histologies 115
A Novel Classification Proposal for Rectourethral Fistulas After Primary Treatment of Prostate Cancer 115
Preoperative Erectile Function Represents a Significant Predictor of Postoperative Urinary Continence Recovery in Patients Treated With Bilateral Nerve Sparing Radical Prostatectomy 115
Long-term Outcomes of Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: Not as Good as Previously Thought 112
ASSOCIATION BETWEEN BRCA 1/2 POLYMORPHISMS AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 112
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 110
Incidence and Clinical Impact of Inflammatory Fluorodeoxyglucose Positron Emission Tomography Uptake After Neoadjuvant Pembrolizumab in Patients with Organ-confined Bladder Cancer Undergoing Radical Cystectomy 109
Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent 108
A Systematic Review of Focal Ablative Therapy for Clinically Localised Prostate Cancer in Comparison with Standard Management Options: Limitations of the Available Evidence and Recommendations for Clinical Practice and Further Research 108
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 107
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 106
DNA methylation alterations in prostate cancer: from diagnosis to treatment 104
Diagnostic and prognostic factors in patients with prostate cancer: A systematic review protocol 104
"Trifecta' outcomes of robot-assisted partial nephrectomy in solitary kidney: a Vattikuti Collective Quality Initiative (VCQI) database analysis 102
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 102
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 101
A NOVEL TOOL FOR THE PREDICTION OF URINARY INCONTINENCE AFTER BILATERAL NERVE SPARING RADICAL PROSTATECTOMY 101
Defining the Most Informative Intermediate Clinical Endpoints for Patients Treated with Salvage Radiotherapy for Prostate-specific Antigen Rise After Radical Prostatectomy 101
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 100
Association Between Prostate Imaging Reporting and Data System (PI-RADS) Score for the Index Lesion and Multifocal, Clinically Significant Prostate Cancer 100
Association of neurovascular bundle preservation with oncological outcomes in patients with high-risk prostate cancer 100
A detailed analysis of the association between postoperative phosphodiesterase type 5 inhibitor use and the risk of biochemical recurrence after radical prostatectomy 99
Development and Validation of a Clinical Prognostic Stage Group System for Nonmetastatic Prostate Cancer Using Disease-Specific Mortality Results from the International Staging Collaboration for Cancer of the Prostate 99
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies 99
A novel tool for the prediction of urinary incontinence after bilateral nerve-sparing radical prostatectomy 97
ASSOCIATION BETWEEN RS6152 POLYMORPHISM IN THE ANDROGEN RECEPTOR GENE AND DISEASE AGGRESSIVENESS IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 96
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 96
A SINGLE POSITIVE LYMPH NODE HAS NO DETRIMENTAL EFFECT ON SURVIVAL OF PATIENTS WITH PROSTATE CANCER TREATED WITH EXTENDED PELVIC LYMPH NODE DISSECTION. RESULTS OF A MATCHED CONTROLLED ANALYSIS 96
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 96
Radioguided Surgery for Prostate Cancer 95
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 95
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 94
Predictors of 30-day acute kidney injury following radical and partial nephrectomy for renal cell carcinoma 94
Effectiveness of a Combination of Cranberries, Lactobacillus rhamnosus, and Vitamin C for the Management of Recurrent Urinary Tract Infections in Women: Results of a Pilot Study 93
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 93
Assessing the Impact of Surgeon Experience on Urinary Continence Recovery after Robot-Assisted Radical Prostatectomy: Results of Four High-Volume Surgeons 93
Definition and Impact on Oncologic Outcomes of Persistently Elevated Prostate-specific Antigen After Salvage Lymph Node Dissection for Node-only Recurrent Prostate Cancer After Radical Prostatectomy: Clinical Implications for Multimodal Therapy 92
Introducing PIONEER: a project to harness big data in prostate cancer research 91
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 90
Assessing the Best Surgical Template at Salvage Pelvic Lymph Node Dissection for Nodal Recurrence of Prostate Cancer After Radical Prostatectomy: When Can Bilateral Dissection be Omitted? Results from a Multi-institutional Series 90
Surgical Safety of Radical Cystectomy and Pelvic Lymph Node Dissection Following Neoadjuvant Pembrolizumab in Patients with Bladder Cancer: Prospective Assessment of Perioperative Outcomes from the PURE-01 Trial 88
Can Patients with Muscle-invasive Bladder Cancer and Fibroblast Growth Factor Receptor-3 Alterations Still Be Considered for Neoadjuvant Pembrolizumab? A Comprehensive Assessment from the Updated Results of the PURE-01 Study 88
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer—2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent 87
A single positive lymph node has no detrimental effect on survival of patients with prostate cancer treated with extended pelvic lymph node dissection. Results of a matched controlled analysis 85
Long-term utility of adjuvant hormonal and radiation therapy for patients with seminal vesicle invasion at radical prostatectomy 85
Early Catheter Removal after Robot-assisted Radical Prostatectomy: Surgical Technique and Outcomes for the Aalst Technique (ECaRemA Study) 85
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer. Part II—2020 Update: Treatment of Relapsing and Metastatic Prostate Cancer 85
Reply by Authors 84
Conversion of Robot-assisted Partial Nephrectomy to Radical Nephrectomy: A Prospective Multi-institutional Study 83
Author Correction: Introducing PIONEER: a project to harness big data in prostate cancer research (Nature Reviews Urology, (2020), 17, 6, (351-362), 10.1038/s41585-020-0324-x) 83
Health-related Quality of Life in Patients with Advanced Prostate Cancer: A Systematic Review 83
Long-term Cancer Control Outcomes in Patients with Clinically High-risk Prostate Cancer Treated with Robot-assisted Radical Prostatectomy: Results from a Multi-institutional Study of 1100 Patients 82
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis 81
Safety and Early Oncologic Outcomes of Lung Resection in Patients with Isolated Pulmonary Recurrent Prostate Cancer: A Single-center Experience 81
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 81
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 81
Prostate-specific Membrane Antigen Imaging in Clinical Guidelines: European Association of Urology, National Comprehensive Cancer Network, and Beyond 81
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 80
Improving the stratification of intermediate risk prostate cancer 80
Technical and Functional Validation of a Teleoperated Multirobots Platform for Minimally Invasive Surgery 79
Controversies in MR targeted biopsy: alone or combined, cognitive versus software-based fusion, transrectal versus transperineal approach? 79
A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer 79
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 77
Does HistoScanning (TM) predict positive results in prostate biopsy? A retrospective analysis of 1,188 sextants of the prostate 77
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 76
A systematic review of the association between erectile dysfunction and cardiovascular disease 76
A Systematic Review of the Emerging Role of Immune Checkpoint Inhibitors in Metastatic Castration-resistant Prostate Cancer: Will Combination Strategies Improve Efficacy? 76
Totale 12.856
Salva come PNG Salva come JPEG
Categoria #
all - tutte 189.969
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 189.969
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022364 0 48 39 116 13 19 31 24 10 14 21 29
2022/20232.140 964 443 116 26 15 230 91 136 59 8 28 24
2023/20241.237 24 48 106 92 89 214 116 126 16 110 122 174
2024/20256.038 829 157 149 140 174 496 722 500 1.105 887 407 472
2025/202617.773 1.213 1.445 1.359 2.567 1.190 399 1.476 1.188 4.589 1.002 700 645
2026/20272.087 1.171 916 0 0 0 0 0 0 0 0 0 0
Totale 29.925